Breast Cancer News
In this section, access cutting-edge news about newly diagnosed breast cancer including treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
LOS ANGELES (Reuters) - Combining experimental antibody drug pertuzumab with Herceptin, an antibody first approved in 1998, and chemotherapy shrank tumors in nearly half of newly diagnosed breast cancer patients treated in a clinical trial.
NEW YORK (Reuters) - The Novartis osteoporosis drug Zometa failed to improve disease free survival of early breast cancer patients in a large clinical trial, but some benefit was observed in older patients who took the medicine, researchers said.
NEW YORK (Reuters Health) - Breast cancer survivors who struggle with hot flashes may find respite in an antidepressant, according to a new study that suggests the medication should be the go-to drug when the overheating is severe.
NEW YORK (Reuters Health) - Women who have breast reconstruction after cancer surgery tend to be happier with the cosmetic results of silicone implants than with saline-filled ones, a study published Monday suggests.
Taking aspirin regularly may decrease risk of death from breast cancer and risk of breast cancer metastasis for women who have had early-stage breast cancer, an analysis indicates.
Three weeks of higher dose radiation worked as well as the standard-dose, five-week schedule after a lumpectomy for invasive, lymph node-negative disease, study shows.
New standards for ER, PR tests in breast cancer have been released by American Society of Clinical Oncology and College of American Pathologists.
Herceptin-based treatments without anthracyclines caused fewer cases of heart failure than treatments containing anthracyclines, study at San Antonio Symposium shows.
Increased access to treatment and follow-up care, protection of coverage in case of job change or loss, ensuring coverage despite pre-existing conditions and increasing quality and quantity of life for young women are among the ways the healthcare overhaul bill may impact people with a history of breast cancer.
Prophylactic mastectomy is recommended only for women at high risk for developing breast cancer, according to new NCCN guidelines.